Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Eric Springman is listed as Biotech Advisor & Entrepreneur at Paint Therapeutics, based in Punta Gorda, Florida, United States. AeroLeads shows a matched LinkedIn profile for Eric Springman.
Eric Springman previously worked as Co-Founder and Chief Operating Officer at Paint Therapeutics and Founder, President & Chief Scientific Officer at Soleil Therapeutics. Eric Springman holds Postdoctoral, Allergy And Immunology, Clinical Pharmacology from Vanderbilt University School Of Medicine.
This section adds company-level context without repeating Eric Springman's masked contact details.
Review company-level records connected to Eric Springman before choosing the right outreach path.
Dr Springman is the Founder & President of Illuma Biosciences. Through his company, he assists academic innovators, independent IP holders and early-stage biotech companies in bringing their concepts from the page to clinical proof-of-concept. His current clients span a range of therapeutic and diagnostic areas including cancer, fibrosis, immunology and inflammatory conditions.During his 25-year industry career, Dr Springman has brought many new investigational medicines from discovery to clinic in disease conditions ranging from inflammation and fibrosis to osteoporosis and cancer. He completed his postdoctoral training in Clinical Pharmacology and Immunology at Vanderbilt University School of Medicine, where he was an American Lung Association Research Fellow. He holds a PhD in Molecular Biophysics from Florida State University, where his graduate work was presented at the 1998 Nobel Mini-Forum. Dr Springman is a past member of the Pennsylvania Drug, Device and Cosmetics Board and the GABIO Board of Directors.For details of Dr Springman's publications, please see the ResearchGate link in the "Featured" section.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Paint Therapeutics is an Atlanta-based emerging biotech developing a pipeline of conjugate-based drugs based on proprietary delivery platforms to improve distribution and residence time in the targeted tissue, led by our PulmoPaint platform for lung indications. Other platforms under development include brain and gastrointestinal targeting technologies.
Soleil Therapeutics licenses and develops innovative therapeutic agents at an early stage that need a bit of TLC before they are ready for formal investment. Our mission is to serve as a bridge between the creative academic scientist and the pragmatic pharmaceutical and venture capital investor by building a product package with a clear rationale and.
Atlanta, GA, US
Radyus Research is a contract preclinical advisory group proving scientific expertise, strategic guidance, and operational implementation for its clients, who rely on Radyus to help successfully take their drug to IND.
Pharmaceutical / Biotechnology Executive and Operational Consulting
Quick answers generated from the profile data available on this page.
Eric Springman works for Paint Therapeutics.
Eric Springman is listed as Biotech Advisor & Entrepreneur at Paint Therapeutics.
Eric Springman is based in Punta Gorda, Florida, United States while working with Paint Therapeutics.
Eric Springman has worked for Paint Therapeutics, Soleil Therapeutics, Radyus Research, Illuma Biosciences, and Celtaxsys, Inc..
You can use AeroLeads to view verified contact signals for Eric Springman at Paint Therapeutics, including work email, phone, and LinkedIn data when available.
Eric Springman holds Postdoctoral, Allergy And Immunology, Clinical Pharmacology from Vanderbilt University School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts